Faron Pharmaceuticals

Virtual drug company

Synergistics technologies

Drug candidates

Recent news
Faron was granted Young Innovative Company -status by Tekes
Stock offering for Faron shareholders provided EUR 1.25 millions of new capital for Traumakine-program
First Traumakine®-related patent granted for Faron
Faron and Rentschler to co-operate on Traumakine® development
More news...

Faron is a virtual drug company focusing to discovery and development of proprietary new compounds/use for:

 

• vasculopathies

• traumas

• inflammation

• metastasis